-
1077HS/4: PREDICTORS OF VIREMIA IN POSTPARTUM WOMEN ON ANTIRETROVIRAL THERAPY
Journal of Acquired Immune Deficiency Syndrome, January 2020 Undetectable viral load is associated with optimal health outcomes for people living with HIV.
Jan 01, 2020
-
A5260S: FUNGAL MARKER Β-D-GLUCAN INCREASED AFTER ANTIRETROVIRAL THERAPY, ASSOCIATED WITH FAT GAINS
Open Forum Infectious Diseases, November 2019 A5260s was a sub-study of A5257 in which ART-naïve individuals with HIV were randomized to receive atazanavir (ATV)/ritonavir (r), darunavir/r, or raltegravir.
Nov 19, 2019
-
ANTIRETROVIRAL TREATMENT INTERRUPTIONS LOOK DIFFERENT IN POSTPARTUM WOMEN THAN IN MEN
Wolters Kluwer, November 2019 The short-term safety of treatment interruptions (a necessary part of cure studies) is not well-established, particularly in women and racially diverse populations.
Nov 15, 2019
-
A5334S: DIFFERENCES IN DRUG INTERACTIONS BETWEEN THOSE WITH HCV, HIV, AND HIV/HCV COINFECTION
British Journal of Pharmacology, October 2019 One form of treatment for Hepatitis C virus (HCV) is composed of ombitasvir, paritaprevir/ritonavir- plus dasabuvir (OBV/PTV/r + DSV), and weight-based ribavirin.
Oct 27, 2019
-
Clinical Infectious Diseases, November 2019 A5288 assessed third-line antiretroviral treatment (ART) in individuals who were failing second-line ART.
Oct 01, 2019
-
SCREENING AND ENROLLMENT BY SEX IN HUMAN IMMUNODEFICIENCY VIRUS CLINICAL TRIALS IN THE UNITED STATES
Clinical Infectious Diseases, September 2019 While women represent about one-quarter of adults living with HIV in the United States and over half of people living with HIV worldwide, many HIV clinical trials enroll fewer than 25% women.
Sep 29, 2019
-
ACTG DACS 325: SCREENING AND ENROLLMENT BY SEX IN HIV CLINICAL TRIALS IN THE UNITED STATES
Clinical Infectious Diseases, September 2019 While women represent about one-quarter of adults living with HIV in the United States, many HIV clinical trials enroll fewer than 25% women.
Sep 29, 2019
-
LINKED DUAL-CLASS HIV RESISTANCE MUTATIONS ASSOCIATED WITH TREATMENT FAILURE
JCI insight, September 2019 Ultrasensitive sequencing of HIV can reveal drug resistance mutations present at very low frequencies, but the clinical significance of those viral resistance mutations remains unknown.
Sep 05, 2019
-
The Lancet HIV, September 2019 Tuberculosis (TB) coinfection among pregnant women living with HIV is associated with poor outcomes so effective contraception to prevent unintended pregnancy is of paramount importance for young women with HIV and TB.
Sep 01, 2019
-
THE IMPACT OF ART ON THE EFFICACY OF VAGINALLY DELIVERED HORMONAL CONTRACEPTION
The Lancet HIV, September 2019 ACTG Changes Guidelines Effective family planning, which often involves the use of hormonal contraception, is an important component of care for women living with HIV.
Sep 01, 2019
-
A LANDMARK ACTG STUDY EVALUATING SECOND-LINE ART FAILURE IN LOW- AND MIDDLE-INCOME COUNTRIES
The Lancet HIV, September 2019 Prolonging the success of ART regimens in light of earlier starts and therapy over a lifetime requires innovative monitoring and treatment strategies.
Sep 01, 2019
-
THE IMPACT OF ART ON THE EFFICACY OF VAGINALLY DELIVERED HORMONAL CONTRACEPTION
The Lancet HIV, September 2019 ACTG Changes Guidelines Effective family planning, which often involves the use of hormonal contraception, is an important component of care for women living with HIV.
Sep 01, 2019
